Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated combining chemotherapy with peripheral stem cell transplantation for epithelial ovarian cancer and primary perit…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer [Phase 1]
Phase 1 trial evaluating a radiolabeled monoclonal antibody with paclitaxel and interferon alfa in patients with recurrent ovarian cancer ha…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 3]
A Phase 3 trial comparing paclitaxel and carboplatin with or without epirubicin in stage IIB-IV invasive ovarian epithelial, fallopian tube,…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma [Phase 2]
Phase 2 study evaluating the combination of docetaxel and gemcitabine for platinum-resistant ovarian cancer and primary peritoneal carcinoma…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating 3-AP (triapine) with cisplatin in patients with recurrent or persistent platinum-resistant ovarian epithelial or pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial of imatinib mesylate in patients with Stage III or Stage IV ovarian epithelial cancer or primary peritoneal cancer has co…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
This entry reports the completion status of a Phase 2 trial evaluating interleukin-12 in patients with ovarian epithelial cancer or primary …
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial evaluating volociximab (M200) in combination with liposomal doxorubicin for ovarian cance…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer [Phase 2]
Phase 2 trial evaluating EF5 as an imaging agent to detect tumor hypoxia in patients with cervical, endometrial, or ovarian cancers undergoi…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating cisplatin and gemcitabine in patients with refractory or recurrent ovarian epithelial, fallopian tube, or primary p…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer [NA]
This trial evaluated EF5 as a hypoxia marker to detect oxygen levels and vasculature in tumor cells during photodynamic therapy for intraper…
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Phase 1]
Phase I trial evaluating the SRC kinase inhibitor dasatinib in combination with paclitaxel and carboplatin for ovarian, peritoneal, and fall…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating sorafenib (Nexavar) versus placebo as maintenance therapy in advanced ovarian or primary peritoneal cancer; results…
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: S9912 Combination Chemo in Stage III Ovarian Cancer, [Phase 2]
Phase 2 trial S9912 evaluated a combination chemotherapy regimen in stage III ovarian cancer; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer [Phase 1]
Phase I trial evaluating ovarian cancer peptides plus GM-CSF as adjuvant therapy for epithelial ovarian cancer, fallopian tube cancer, or pe…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: ChemoFx® PRO - A Post-Market Data Collection Study
The post-market data collection study ChemoFx PRO by Precision Therapeutics has been terminated, with data collection across ovarian and rel…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
This terminated clinical trial evaluated whether a chemoresponse assay correlates with progression-free survival in patients with recurrent …
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Phase 2]
Phase II trial evaluating the activity of pegaspargase in women with relapsed or refractory epithelial ovarian cancer, fallopian tube cancer…
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer [Phase 2]
Phase 2 SWOG trial evaluating the combination of chemotherapy and surgery for stage III or IV ovarian cancer; results were posted after comp…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2, single-arm study of volociximab monotherapy in platinum-resistant advanced epithelial ovarian cancer and primary peritoneal cancer …
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating docetaxel in women with ovarian epithelial cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating PS-341 (bortezomib) in combination with carboplatin for platinum- and taxane-resistant recurrent ovarian cancer, pr…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating PEG-interferon alfa-2b in platinum-resistant ovarian, fallopian tube, and peritoneal cancer.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial evaluated vandetanib for ovarian, fallopian tube, and primary peritoneal cancers; the study was terminated and results we…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 study of arzoxifene hydrochloride in women with metastatic refractory ovarian cancer or primary peritoneal cancer; the trial has com…